News & Updates

High consumption of ultra-processed foods appears to increase the risk of all-cause mortality, cardiovascular disease (CVD)-related mortality, common mental disorders, overweight and obesity, and type 2 diabetes (T2D), reveals the results of an umbrella review of epidemiological meta-analyses.

Treatment with semaglutide 2.4 mg results in clinically meaningful weight loss, irrespective of baseline antidepressant (AD) use, among adults with overweight/obesity, reports a post hoc study of the Semaglutide Treatment Effect for People with obesity (STEP).